Healthcare

Sexually Transmitted Diseases (STD) Testing Market by Disease Type (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus, Human Papilloma Virus, Human Immunodeficiency Virus, and Others), and Location of Testing (Laboratory Testing and POC Testing): Global Opportunity Analysis and Industry Forecast, 2018–2025

  • ALL3201211
  • 110 Pages
  • May 2019
  • Healthcare
Download Sample    Get Discount   
 
The global STD testing market was valued at $ 86,548.0 million in 2017 and is estimated to reach $ 133,935.7 million by 2025, growing at a CAGR of 5.6% from 2018 to 2025.

Sexually transmitted diseases are considered as one of the most critical health challenges globally. Chlamydia, gonorrhea, and herpes simplex virus are some of the highly prevalent sexually transmitted diseases. The STD testing market has witnessed significant growth in the past decade with increasing prevalence of STDs. With high prevalence, coverage of STD diagnosis facilities has also majorly increased in the developed countries. However, in developing regions, STD diagnosis facilities are still inadequate to provide wider coverage to the population with STDs. Inadequate facilities for STD diagnosis are considered to be the major concern in developing regions.

STDs have witnessed substantial growth in their prevalence and incidents in the past decade. With increasing prevalence, respective countries across the world are focusing on implementation of national screening programs to expand the coverage of STD diagnosis. Moreover, reimbursement policies have also been favorable for STD services. These factors are significantly driving the growth of the global STD testing market. On the other hand, limited access to STD diagnosis in developing regions is expected to restrain the market growth.

STD Testing Market

Get more information on this report : Request Sample Pages

GLOBAL STD TESTING MARKET SEGMENTATION

The global STD testing market is segmented based on disease type, location of testing, and region. Based on disease type, it is bifurcated into chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus, human immunodeficiency virus testing, and others. Based on location of testing, the market is categorized into laboratory testing, and point of care (PoC) testing. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

STD Testing Market By Region

Get more information on this report : Request Sample Pages

Segment review

According to disease type, the chlamydia segment is the highest revenue contributor and gonorrhea is expected to exhibit the fastest growth rate of 8.9%. This is attributed to the increased prevalence of gonorrhea in the last decade.

STD Testing Market By Type

Get more information on this report : Request Sample Pages

By location of testing, the laboratory testing segment occupied the largest share of STD testing market in 2017. POC testing segment is expected to grow at the highest rate during the forecast period. Factors such as faster diagnosis with POC tests and expected rise in adoption of POCs in future significantly contribute toward the growth of this segment.

STD Testing Market By Testing

Get more information on this report : Request Sample Pages

Key Benefits for Std Testing Market:

This report entails a detailed quantitative analysis along with the current global STD testing market trends from 2017 to 2025 to identify the prevailing opportunities along with the strategic assessment.

The global STD testing market forecast is studied from 2018 to 2025.

The global STD testing market size and estimations are based on a comprehensive analysis of key developments in the industry.

A qualitative analysis based on innovative products facilitates strategic business planning.

The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

Std Testing Market Segmentation:

By Disease Type

Chlamydia

Syphilis

Gonorrhea

Herpes Simplex Virus

Human Papilloma Virus

Human Immunodeficiency Virus

Others

By Location of Testing

Laboratory Testing

Point of Care (POC) Testing

By Region

North America

Europe

Asia-Pacific

LAMEA

Latin America

Middle East

South Africa

Other African Countries

CHAPTER 1:INTRODUCTION

1.1.REPORT DESCRIPTION

1.2.KEY MARKET SEGMENTS

1.3.KEY BENEFITS

1.4.RESEARCH METHODOLOGY

1.4.1.Primary research

1.4.2.Secondary research

1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO PERSPECTIVE

CHAPTER 3:MARKET OVERVIEW

3.1.MARKET DEFINITION AND SCOPE

3.2.KEY FINDINGS

3.2.1.Top investment pockets

3.2.2.Top winning strategies

3.3.MARKET DYNAMICS

3.3.1. Drivers

3.3.2. Restraints

3.3.3. Opportunities

CHAPTER 4:STD TESTING MARKET BY DISEASE TYPE

4.1.OVERVIEW

4.2. CHLAMYDIA

4.2.1.Key market trends, Growth factors and opportunities

4.2.2.Market size and forecast by region

4.2.3.Market volume and forecast by region

4.3. GONORRHEA

4.3.1.Key market trends, Growth factors and opportunities

4.3.2.Market size and forecast by region

4.3.3.Market volume and forecast by region

4.4. HERPES SIMPLEX VIRUS

4.4.1.Key market trends, Growth factors and opportunities

4.4.2.Market size and forecast by region

4.4.3.Market volume and forecast by region

4.5. SYPHILIS

4.5.1.Key market trends, Growth factors and opportunities

4.5.2.Market size and forecast by region

4.5.3.Market volume and forecast by region

4.6. HUMAN PAPILLOMA VIRUS

4.6.1.Key market trends, Growth factors and opportunities

4.6.2.Market size and forecast by region

4.6.3.Market volume and forecast by region

4.7. HUMAN IMMUNODEFICIENCY VIRUS

4.7.1.Key market trends, Growth factors and opportunities

4.7.2.Market size and forecast by region

4.7.3.Market volume and forecast by region

4.8. OTHERS

4.8.1.Key market trends, Growth factors and opportunities

4.8.2.Market size and forecast by region

4.8.3.Market volume and forecast by region

CHAPTER 5:STD TESTING MARKET BY LOCATION OF TESTING

5.1.OVERVIEW

5.2. LABORATORY TESTING

5.2.1.Key market trends, Growth factors and opportunities

5.2.2.Market size and forecast by region

5.2.3.Market volume and forecast by region

5.3. POINT OF CARE TESTING

5.3.1.Key market trends, Growth factors and opportunities

5.3.2.Market size and forecast by region

5.3.3.Market volume and forecast by region

CHAPTER 6:STD TESTING MARKET BY REGION

6.1.OVERVIEW

6.2.NORTH AMERICA

6.2.1.Key market trends and opportunities

6.2.2.Market size and forecast by Disease Type

6.2.3.Market size and forecast by Location of Testing

6.3.EUROPE

6.3.1.Key market trends and opportunities

6.3.2.Market size and forecast by Disease Type

6.3.3.Market size and forecast by Location of Testing

6.4.ASIA PACIFIC

6.4.1.Key market trends and opportunities

6.4.2.Market size and forecast by Disease Type

6.4.3.Market size and forecast by Location of Testing

6.5.LAMEA

6.5.1.Key market trends and opportunities

6.5.2.Market size and forecast by Disease Type

6.5.3.Market size and forecast by Location of Testing

CHAPTER 7:COMPANY PROFILES

7.1. ROCHE HOLDINGS AG

7.1.1.Company overview

7.1.2.Business performance

7.1.3.Key strategic moves and developments

7.2. BIOMERIEUX

7.2.1.Company overview

7.2.2.Business performance

7.2.3.Key strategic moves and developments

7.3. HOLOGIC INC

7.3.1.Company overview

7.3.2.Business performance

7.3.3.Key strategic moves and developments

7.4. BECTON DICKINSON COMPANY

7.4.1.Company overview

7.4.2.Business performance

7.4.3.Key strategic moves and developments

7.5. ORASURE

7.5.1.Company overview

7.5.2.Business performance

7.5.3.Key strategic moves and developments

7.6. DANAHER CORPORATION

7.6.1.Company overview

7.6.2.Business performance

7.6.3.Key strategic moves and developments

7.7. AFFYMETRIX

7.7.1.Company overview

7.7.2.Business performance

7.7.3.Key strategic moves and developments

7.8. ABBOTT LABORATORIES

7.8.1.Company overview

7.8.2.Business performance

7.8.3.Key strategic moves and developments

7.9. BIO-RAD LABORATORIES INC

7.9.1.Company overview

7.9.2.Business performance

7.9.3.Key strategic moves and developments

7.10. DIASORIN

7.10.1.Company overview

7.10.2.Business performance

7.10.3.Key strategic moves and developments

LIST OF TABLES

TABLE 1.GLOBAL STD TESTING MARKET, BY DISEASE TYPE 2017-2025 ($MILLION)

TABLE 2.STD TESTING MARKET FOR CHLAMYDIA, BY REGION, 2017-2025 ($MILLION)

TABLE 3.STD TESTING MARKET FOR GONORRHEA, BY REGION, 2017-2025 ($MILLION)

TABLE 4.STD TESTING MARKET FOR HERPES SIMPLEX VIRUS, BY REGION, 2017-2025 ($MILLION)

TABLE 5.STD TESTING MARKET FOR SYPHILIS, BY REGION, 2017-2025 ($MILLION)

TABLE 6.STD TESTING MARKET FOR HUMAN PAPILLOMA VIRUS, BY REGION, 2017-2025 ($MILLION)

TABLE 7.STD TESTING MARKET FOR HUMAN IMMUNODEFICIENCY VIRUS, BY REGION, 2017-2025 ($MILLION)

TABLE 8.STD TESTING MARKET FOR OTHERS, BY REGION, 2017-2025 ($MILLION)

TABLE 9.GLOBAL STD TESTING MARKET, BY LOCATION OF TESTING 2017-2025 ($MILLION)

TABLE 10.STD TESTING MARKET FOR LABORATORY TESTING, BY REGION, 2017-2025 ($MILLION)

TABLE 11.STD TESTING MARKET FOR POINT OF CARE TESTING, BY REGION, 2017-2025 ($MILLION)

TABLE 12.STD TESTING MARKET FOR, BY REGION, 2017-2025 ($MILLION)

TABLE 13.NORTH AMERICA STD TESTING, BY DISEASE TYPE 2017-2025 ($MILLION)

TABLE 14.NORTH AMERICA STD TESTING, BY LOCATION OF TESTING 2017-2025 ($MILLION)

TABLE 15.NORTH AMERICA STD TESTING, BY REGION, 2017-2025 ($MILLION)

TABLE 16.EUROPE STD TESTING, BY DISEASE TYPE 2017-2025 ($MILLION)

TABLE 17.EUROPE STD TESTING, BY LOCATION OF TESTING 2017-2025 ($MILLION)

TABLE 18.EUROPE STD TESTING, BY REGION, 2017-2025 ($MILLION)

TABLE 19.ASIA PACIFIC STD TESTING, BY DISEASE TYPE 2017-2025 ($MILLION)

TABLE 20.ASIA PACIFIC STD TESTING, BY LOCATION OF TESTING 2017-2025 ($MILLION)

TABLE 21.ASIA PACIFIC STD TESTING, BY REGION, 2017-2025 ($MILLION)

TABLE 22.LAMEA STD TESTING, BY DISEASE TYPE 2017-2025 ($MILLION)

TABLE 23.LAMEA STD TESTING, BY LOCATION OF TESTING 2017-2025 ($MILLION)

TABLE 24.LAMEA STD TESTING, BY REGION, 2017-2025 ($MILLION)

TABLE 25.ROCHE HOLDINGS AG: COMPANY SNAPSHOT

TABLE 26.ROCHE HOLDINGS AG: OPERATING SEGMENTS

TABLE 27.BIOMERIEUX: COMPANY SNAPSHOT

TABLE 28.BIOMERIEUX: OPERATING SEGMENTS

TABLE 29.HOLOGIC INC: COMPANY SNAPSHOT

TABLE 30.HOLOGIC INC: OPERATING SEGMENTS

TABLE 31.BECTON DICKINSON COMPANY: COMPANY SNAPSHOT

TABLE 32.BECTON DICKINSON COMPANY: OPERATING SEGMENTS

TABLE 33.ORASURE: COMPANY SNAPSHOT

TABLE 34.ORASURE: OPERATING SEGMENTS

TABLE 35.DANAHER CORPORATION: COMPANY SNAPSHOT

TABLE 36.DANAHER CORPORATION: OPERATING SEGMENTS

TABLE 37.AFFYMETRIX: COMPANY SNAPSHOT

TABLE 38.AFFYMETRIX: OPERATING SEGMENTS

TABLE 39.ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 40.ABBOTT LABORATORIES: OPERATING SEGMENTS

TABLE 41.BIO-RAD LABORATORIES INC: COMPANY SNAPSHOT

TABLE 42.BIO-RAD LABORATORIES INC: OPERATING SEGMENTS

TABLE 43.DIASORIN: COMPANY SNAPSHOT

TABLE 44.DIASORIN: OPERATING SEGMENTS

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370